Source: Value in health. Conference titles: ISPOR Annual international meeting. Unidade: FM
Subjects: REVISÃO SISTEMÁTICA, IDOSOS, VACINAÇÃO, CUSTOS DOS CUIDADOS DE SAÚDE
ABNT
NISHIKAWA, A. M et al. Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 out. 2024. , 2017APA
Nishikawa, A. M., Mainardi, G. M., Novaes, H. M. D., Sartori, A. M. C., & Soarez, P. C. de. (2017). Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. New York: Faculdade de Medicina, Universidade de São Paulo.NLM
Nishikawa AM, Mainardi GM, Novaes HMD, Sartori AMC, Soarez PC de. Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. 2017 ; 20( 5): A932-A932.[citado 2024 out. 10 ]Vancouver
Nishikawa AM, Mainardi GM, Novaes HMD, Sartori AMC, Soarez PC de. Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. 2017 ; 20( 5): A932-A932.[citado 2024 out. 10 ]